ImmuCell Corporation Cash
ImmuCell Corporation (ICCC) had Cash of $30.67 thousand as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2023-05-11
- 2022-12-31: Cash $30.67K.
- 2022-09-30: Cash $30.67K.
- 2022-03-31: Cash $5.84K.
| Period end | Cash |
|---|---|
| 2022-12-31 | $30.67K 10-K · filed 2023-03-29 |
| 2022-09-30 | $30.67K 10-Q · filed 2022-11-21 |
| 2022-03-31 | $5.84K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |